Publications

Show Filters

Searches all publications.

Search Term

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-21
    E.g., 2018-06-21

Articles

257235 items
12:00 AM, May 30, 1995  |  BC Week In Review | Clinical News  |  Clinical Results

Adaprolol beta blocker in a submicron emulsion formulation data

PARS (New York) presented early clinical data at the Fort Lauderdale meeting, showing that Adaprolol reduced intraocular pressure (p<0.01) in 63 patients as did the comparison beta blocker, timolol. In contrast to timolol, the company's...
12:00 AM, May 30, 1995  |  BioCentury | Analyst Picks & Changes

Analyst picks & changes

Amgen Inc. (AMGN) Josephthal, Lyon & Ross analyst Franklin Berger said the Thousand Oaks, Calif., company still has plenty of room to grow its Neupogen G-CSF market just by fully penetrating standard chemotherapy markets....
12:00 AM, May 30, 1995  |  BioCentury | Analyst Picks & Changes

Analyst picks & changes

Genzyme Corp. (GENZ) Merrill's van den Broek said that GENZ (Cambridge, Mass.) is fairly valued at $40 until the HAL-F and HAL-C data on surgical adhesions are released. With its lead product, Ceredase / ...
12:00 AM, May 30, 1995  |  BC Week In Review | Company News  |  Deals

Genzyme Transgenics deal

GZTC (Framingham, Mass.) will purchase Biodevelopment Laboratories for $6 million. GZTC will issue common shares with a value of $2.6 million and will assume Biodevelopment's $2.7 million of outstanding debt, in addition to other considerations....
12:00 AM, May 30, 1995  |  BioCentury | Analyst Picks & Changes

Analyst picks & changes

Centocor Inc. (CNTO) Joyce Lonergan of Cowen & Co. said she wasn't surprised that the interim look at CNTO's CAPTURE trial of ReoPro in unstable angina didn't show sufficient efficacy to stop the study...
12:00 AM, May 30, 1995  |  BC Week In Review | Company News  |  Other News

Medco news

Medco Research Inc. (MRE)   MRE (Research Triangle Park, N.C.) settled litigation with partner Fujisawa USA Inc., which MRE sued two years ago for breach of contract when Fujisawa couldn't get its plants qualified for GMP...
12:00 AM, May 30, 1995  |  BioCentury | Finance

Genzyme Corp. (GENZ)

Genzyme Corp. (GENZ) The weekly change in the indexed market value of Genzyme Corp. (GENZ) (dotted line with triangles) compared to The Carson Life Sciences Index of large cap companies (>$500M). The initial index value is...
12:00 AM, May 30, 1995  |  BC Week In Review | Company News  |  Deals

Isis deal

Ciba-Geigy Ltd. has accepted ISIS 5132 (CGP 69846 A), an antisense cancer drug, as an early development compound under the companies' cooperative research agreement. The Carlsbad, Calif., company's oligonucleotide is in animal testing against human...
12:00 AM, May 30, 1995  |  BC Week In Review | Company News  |  Other News

Mycogen news

The '831 patent covers methods of modifying Bt gene sequences to make them resemble those of the plants into which they are being inserted. The suit covers insect-resistant cotton and potato products as well as...
12:00 AM, May 30, 1995  |  BioCentury | Tools & Techniques

Venter's short cut

Venter's short cut The private sector has made an end run in the genome sequencing game, coming up with an organism's entire sequence using a short-cut method that the government had refused to fund. Human Genome...

Pages